Search Ontology:
ChEBI
apraclonidine
- Term ID
- CHEBI:2788
- Synonyms
-
- 2,6-dichloro-N(1)-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
- 4-Aminoclonidine
- apraclonidina
- apraclonidine
- apraclonidinum
- Definition
- An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
- References
-
- beilstein:5436106
- cas:66711-21-5
- drugbank:DB00964
- drugcentral:229
- kegg.compound:C07668
- kegg.drug:D07461
- patent:US4517199
- pubmed:17204928
- pubmed:17572343
- pubmed:17580803
- pubmed:17824139
- pubmed:18454417
- pubmed:18645436
- pubmed:18769292
- pubmed:19169332
- pubmed:19253181
- pubmed:19393510
- pubmed:19525731
- pubmed:19606173
- pubmed:19927485
- pubmed:20182200
- pubmed:20399934
- pubmed:21384091
- pubmed:21386103
- pubmed:21406599
- pubmed:21566530
- pubmed:21576682
- pubmed:23808550
- pubmed:24651238
- pubmed:25318185
- pubmed:25709394
- pubmed:25748642
- pubmed:25768246
- pubmed:25859142
- pubmed:26057409
- pubmed:26381100
- pubmed:26832333
- pubmed:27239603
- pubmed:27773627
- pubmed:27841849
- pubmed:27928279
- pubmed:27984360
- pubmed:27990376
- pubmed:28017248
- pubmed:28231380
- pubmed:7891985
- pubmed:9856229
- wikipedia.en:Apraclonidine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from apraclonidine
Phenotype where environments contain apraclonidine
Phenotype modified by environments containing apraclonidine
Phenotype affecting apraclonidine
Human Disease Model